Obeticholic Acid (OCA) 459789-99-2: Premium API for PBC Treatment & NASH Research
Discover Obeticholic Acid, a cutting-edge semi-synthetic bile acid analogue and potent FXR agonist, offering advanced solutions for primary biliary cholangitis and promising research avenues for nonalcoholic steatohepatitis.
Get a Quote & SampleUnlocking the Therapeutic Potential of Obeticholic Acid
Obeticholic Acid
Obeticholic Acid stands as a pivotal Active Pharmaceutical Ingredient (API) in modern pharmacology, recognized for its targeted action against severe liver conditions. Its unique mechanism as an FXR agonist provides a new pathway for therapeutic intervention, particularly for patients with primary biliary cholangitis and those in trials for NASH.
- Highly effective in primary biliary cholangitis treatment, Obeticholic Acid aids in managing this chronic liver condition.
- As a powerful FXR agonist, it plays a crucial role in regulating bile acid synthesis and lipid metabolism, offering significant therapeutic potential.
- Available as a high-quality obeticholic acid API, essential for pharmaceutical formulations globally.
- Actively investigated for its potential in nonalcoholic steatohepatitis (NASH) research, offering new hope for liver disease management.
Key Advantages of Choosing Our Obeticholic Acid
Superior Purity & Efficacy
Our high quality obeticholic acid powder ensures unparalleled purity, meeting stringent medicine grade standards for reliable therapeutic outcomes in PBC treatment.
Targeted Therapeutic Action
As a leading FXR agonist drug development compound, Obeticholic Acid precisely targets pathways critical for managing bile acid-related liver disorders.
Versatile Application Potential
Beyond established primary biliary cholangitis treatment, Obeticholic Acid is a focus for advanced NASH drug research, expanding its therapeutic reach.
Key Applications
Primary Biliary Cholangitis (PBC) Treatment
Crucial for primary biliary cholangitis treatment, Obeticholic Acid helps manage this chronic autoimmune liver disease, improving patient outcomes.
Nonalcoholic Steatohepatitis (NASH) Research
A key compound in NASH drug research, Obeticholic Acid is being explored for its ability to reduce inflammation and fibrosis in the liver.
Bile Acid Diarrhea Studies
Investigated for its role in bile acid diarrhea studies, Obeticholic Acid offers potential insights and treatment options for this gastrointestinal condition.
Pharmaceutical API Production
As a high-demand pharmaceutical API production component, our Obeticholic Acid is vital for manufacturing leading liver medications globally.